Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

EF-CAB13 Inhibitors

EF-CAB13 inhibitors are a class of chemical compounds that target and modulate the activity of EF-CAB13, a calcium-binding protein that is part of the broader family of EF-hand calcium-binding proteins. These proteins play a crucial role in the regulation of intracellular calcium levels, which are pivotal for a variety of cellular processes including signal transduction, muscle contraction, and enzyme activity. EF-CAB13, in particular, is involved in sensing and responding to changes in calcium concentrations within cells, functioning as a mediator that transduces calcium signals into specific cellular responses. By binding to calcium ions, EF-CAB13 undergoes conformational changes that allow it to interact with various target proteins, thereby influencing processes such as gene expression, cell motility, and cell cycle progression.

Inhibitors of EF-CAB13 typically function by interfering with the protein's ability to bind calcium or by disrupting its interaction with target proteins. These inhibitors may bind directly to the calcium-binding sites on EF-CAB13, preventing calcium from binding and thus blocking the conformational changes necessary for its activity. Alternatively, they might induce conformational changes in EF-CAB13 that inhibit its ability to interact with downstream targets, thereby modulating the cellular pathways regulated by calcium signaling. By inhibiting EF-CAB13, researchers can study the specific roles this protein plays in cellular calcium homeostasis and the broader implications of calcium signaling in various biological processes. EF-CAB13 inhibitors are valuable tools in the exploration of calcium-dependent signaling networks, helping to elucidate the complex mechanisms that regulate cellular functions in response to fluctuating calcium levels. Through these studies, scientists can gain deeper insights into the molecular dynamics of calcium binding and the intricate control of cellular activities by calcium signaling proteins.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor that can disrupt signal transduction pathways involving phosphorylation, which may be required for EF-CAB13 activation or stabilization.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can impede the PI3K/Akt pathway, potentially affecting EF-CAB13 if it is regulated by this pathway for membrane localization or function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor that can block the MAPK/ERK pathway, potentially altering EF-CAB13 function if it is modulated by ERK-mediated phosphorylation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor that can impede cellular responses to stress or cytokines, potentially influencing EF-CAB13 if it is involved in these responses.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can affect cell growth and proliferation pathways, potentially affecting EF-CAB13 if it is involved in mTOR signaling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor that can alter multiple signaling pathways, potentially affecting EF-CAB13 activity or expression if it is PI3K-dependent.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which can affect apoptosis and cell differentiation pathways, potentially influencing EF-CAB13 if it is modulated by JNK signaling.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

A Src family kinase inhibitor that can affect cell adhesion, growth, and differentiation, potentially altering EF-CAB13 if it interacts with Src kinases.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

An Aurora kinase inhibitor that can disrupt mitosis and cell division, potentially influencing EF-CAB13 if it plays a role in cell cycle regulation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that can affect protein degradation pathways, potentially stabilizing EF-CAB13 if it is normally targeted for degradation.